| Host: |
Mouse |
| Applications: |
WB/IP |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Mouse monoclonal antibody anti-Retrotransposon-derived protein PEG10 is suitable for use in Western Blot and Immunoprecipitation research applications. |
| Clonality: |
Monoclonal |
| Clone ID: |
1E2-F12-C12 |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG1 |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from mouse ascites by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:1000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
PEG10 |
| Gene ID: |
23089 |
| Uniprot ID: |
PEG10_HUMAN |
| Specificity: |
This antibody detects endogenous levels of PEG10 and does not cross-react with related proteins. |
| Immunogen: |
Purified recombinant human PEG10 protein fragments expressed in E.coli. |
| Post Translational Modifications | Isoform 1: Undergoes proteolytic cleavage. |
| Function | Retrotransposon-derived protein that binds its own mRNA and self-assembles into virion-like capsids. Forms virion-like extracellular vesicles that encapsulate their own mRNA and are released from cells, enabling intercellular transfer of PEG10 mRNA. Binds its own mRNA in the 5'-UTR region, in the region near the boundary between the nucleocapsid (NC) and protease (PRO) coding sequences and in the beginning of the 3'-UTR region. Involved in placenta formation: required for trophoblast stem cells differentiation. Involved at the immediate early stage of adipocyte differentiation. Overexpressed in many cancers and enhances tumor progression: promotes cell proliferation by driving cell cycle progression from G0/G1. Enhances cancer progression by inhibiting the TGF-beta signaling, possibly via interaction with the TGF-beta receptor ACVRL1. May bind to the 5'-GCCTGTCTTT-3' DNA sequence of the MB1 domain in the myelin basic protein (MBP) promoter.additional evidences are however required to confirm this result. |
| Protein Name | Retrotransposon-Derived Protein Peg10Embryonal Carcinoma Differentiation-Regulated ProteinMammalian Retrotransposon-Derived Protein 2Myelin Expression Factor 3-Like Protein 1Mef3-Like Protein 1Paternally Expressed Gene 10 ProteinRetrotransposon Gag Domain-Containing Protein 3Retrotransposon-Derived Gag-Like PolyproteinTy3/Gypsy-Like Protein |
| Cellular Localisation | Extracellular Vesicle MembraneCytoplasmNucleusForms Virion-Like Extracellular Vesicles That Are Released From CellsDetected Predominantly In The Cytoplasm Of Breast And Prostate CarcinomasIn Hepatocellular Carcinoma (Hcc) And B-Cell Chronic Lymphocytic Leukemia (B-Cll) Cells And In The Hep-G2 Cell Line |
| Alternative Antibody Names | Anti-Retrotransposon-Derived Protein Peg10 antibodyAnti-Embryonal Carcinoma Differentiation-Regulated Protein antibodyAnti-Mammalian Retrotransposon-Derived Protein 2 antibodyAnti-Myelin Expression Factor 3-Like Protein 1 antibodyAnti-Mef3-Like Protein 1 antibodyAnti-Paternally Expressed Gene 10 Protein antibodyAnti-Retrotransposon Gag Domain-Containing Protein 3 antibodyAnti-Retrotransposon-Derived Gag-Like Polyprotein antibodyAnti-Ty3/Gypsy-Like Protein antibodyAnti-PEG10 antibodyAnti-EDR antibodyAnti-KIAA1051e antibodyAnti-MAR2 antibodyAnti-MART2 antibodyAnti-MEF3L1 antibodyAnti-RGAG3 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
